If you are already on a GLP-1 medication from another provider, you can maintain your current dose with documentation of your prior prescription
L-Lysine and l-proline contribute to collagen structure and protein synthesis
Common Side Effects Nausea (most common, peaks during dose escalation) Diarrhea, constipation, vomiting Decreased appetite, fatigue, headache Injection-site reactions (injectable forms) Rare: pancreatitis, gallbladder disease, kidney injury FDA boxed warning for medullary thyroid carcinoma (do not use with personal or family history of MTC or MEN2) How to Start GLP-1 Treatment See a clinician in-person primary care, endocrinology, obesity medicine, or US telehealth
PL BioScience has advanced an oral BPC-157 formulation (designated PL-10) to Phase II clinical trials for inflammatory bowel disease representing the most clinically advanced human development of oral BPC-157 to date.3 Human peer-reviewed results from these trials are pending, but the preclinical rationale is strong
Both, but the choice depends on your goal
The distinction matters because it tells you exactly how your medication gets made and under what regulatory framework